FILING ANALYSIS · WEDNESDAY, OCTOBER 28
ACTUATE THERAPEUTICS, INC. ACTU — 8-K: Entry into a Material Definitive Agreement
negative
The company has entered into an underwriting agreement for a public offering of 30,985,900 shares of common stock and warrants to purchase up to 15,492,950 shares, resulting in net proceeds of approximately $9.96 million, which means dilution for existing shareholders
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →